首页> 外文期刊>Fetal and pediatric pathology >Targeted Mutation Analysis of the SLC26A4, MYO6, PJVK and CDH23 Genes in Iranian Patients with AR Nonsyndromic Hearing Loss
【24h】

Targeted Mutation Analysis of the SLC26A4, MYO6, PJVK and CDH23 Genes in Iranian Patients with AR Nonsyndromic Hearing Loss

机译:伊朗患者的SLC26A4,MyO6,PJVK和CDH23基因的靶向突变分析伊朗患者患者AR不合理听力损失

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Hearing loss (HL) is the most prevalent sensory disorder. The over 100 genes implicated in autosomal recessive nonsyndromic hearing loss (ARNSHL) makes it difficult to analyze and determine the accurate genetic causes of hearing loss. We sought to de?ne the frequency of seven hearing loss-Causing causing genetic Variants in four genes in an Iranian population with hearing loss. Materials and methods: One hundred ARNSHL patients with normal GJB2/GJB6 genes were included, and targeted mutations in SLC26A4, MYO6, PJVK and CDH23 genes were analyzed by ARMS-PCR. The negative and positive results were confirmed by the Sanger sequencing. Results: We found only two mutations, one in MYO6 (c.554-1G>A) gene and another in PJVK (c.547C>T). Conclusion: c.554-1G>A and c.547C>T mutations are responsible for 1% each of the Iranian ARNSHL patients. These genes are not a frequent cause of ARNSHL in an Iranian population.
机译:背景:听力损失(HL)是最普遍的感官障碍。 在常染色体隐性非yndromic听力损失(ARNSHL)中有超过100个基因使得难以分析和确定听力损失的准确遗传原因。 我们试图达到伊朗人口中造成六种基因遗传变异的七种听力丧失的频率。 材料和方法:通过Arms-PCR分析了一百个具有正常GJB2 / GJB6基因的ARNSHL患有正常GJB2 / GJB6基因的靶GJB2 / GJB6基因的靶向突变,MYO6,PJVK和CDH23基因。 Sanger测序证实了阴性和阳性结果。 结果:我们发现只有两个突变,一个在MyO6(C.554-1G> A)基因中,另一个在PJVK(C.547C> T)中。 结论:C.554-1G> A和C.547C> T突变负责每种伊朗Arnshl患者的1%。 这些基因不是伊朗人口中ArnShl的常见原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号